Janssen-Cilag's HIV drug gets EU regulatory panel's nod

(Reuters) - A European regulatory panel recommended granting approval to a treatment for HIV infection developed by Janssen-Cilag International, a unit of U.S. drugmaker Johnson& Johnson.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Health